Bristol-Myers Squibb Is Maintained at Equal-Weight by Wells Fargo

Bristol-Myers Squibb Is Maintained at Equal-Weight by Wells Fargo

Dow JonesApr 18 23:14

Bristol-Myers Squibb Price Target Raised to $52.00/Share From $51.00 by Wells Fargo

Bristol-Myers Squibb Price Target Raised to $52.00/Share From $51.00 by Wells Fargo

Dow JonesApr 18 23:14

Wells Fargo Maintains Equal-Weight on Bristol-Myers Squibb, Raises Price Target to $52

Wells Fargo analyst Mohit Bansal maintains Bristol-Myers Squibb (NYSE:BMY) with a Equal-Weight and raises the price target from $51 to $52.

BenzingaApr 18 23:04

Bristol-Myers Squibb Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/18/2024 8.09% Wells Fargo $51 → $52 Maintains Equal-Weight 02/06/2024 6.01% Wells Fargo $58 → $51 Maint

BenzingaApr 18 23:03

Earnings Preview: Bristol Myers Squibb (BMY) Q1 Earnings Expected to Decline

Yahoo FinanceApr 18 22:01

AbbVie Buyout Cerevel Posts Late-stage Win for Parkinson's Disease Drug

Seeking AlphaApr 18 19:00